Michael Overdorf
Patrimonio netto: 1 M $ in data 30/06/2026
Patrimonio netto: 1 M $ in data 30/06/2026
Michael Overdorf is Chief Business Officer & Executive Vice President at Annexon, Inc. since 2020.
Mr. Overdorf was Chief Operating Officer-Bio Medicines at Eli Lilly & Co. from 2001 to 2020.
Mr. Overdorf completed an undergraduate degree at Wabash College in 1992 and earned an MBA from Harvard Business School in 1999.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
ANNEXON, INC. 0,11% | 02/03/2026 | 182.625 ( 0,11% ) | 1 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| ANNEXON, INC. | Corporate Officer/Principal | 30/07/2020 |
| Società | Posizione | Fine |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/07/2020 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Annexon, Inc.
Annexon, Inc. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics for neurodegenerative and autoimmune disorders | Health Technology |
Wabash College
Wabash College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale